| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018675218 |
| P356 | DOI | 10.1023/B:DDAS.0000037803.32013.AA |
| P698 | PubMed publication ID | 15387337 |
| P2093 | author name string | Riccardo Casadei | |
| Patrizia Simoni | |||
| Lucio Gullo | |||
| Maurizio Ventrucci | |||
| Chiara Racchini | |||
| Antonio Cipolla | |||
| P2860 | cites work | Quantification of tumor type M2 pyruvate kinase (Tu M2-PK) in human carcinomas | Q73786026 |
| Quantitative detection of tumor M2-PK in serum and plasma | Q78199915 | ||
| TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions | Q28142360 | ||
| Marker for renal cell carcinoma (RCC): the dimeric form of pyruvate kinase type M2 (Tu M2-PK) | Q28143504 | ||
| The pyruvate kinase isoenzyme tumor M2 (Tu M2-PK) as a tumor marker for renal carcinoma | Q28143510 | ||
| Tumor type M2 pyruvate kinase expression in advanced breast cancer | Q28186200 | ||
| Quantitative detection of tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases | Q28200358 | ||
| Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer | Q33944577 | ||
| Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells. | Q34342590 | ||
| Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. | Q34484280 | ||
| The effects of injury and sepsis on fuel utilization | Q38677557 | ||
| CA19-9: the Italian experience | Q40585837 | ||
| Diagnostic value of tumor M2-pyruvate kinase in neuroendocrine tumors. A comparative study with chromogranin A. | Q44554112 | ||
| The tumor marker tumor M2-PK: an application in the diagnosis of gastrointestinal cancer. | Q52964750 | ||
| Clinical utility of the serum CA 19-9 test for diagnosing pancreatic carcinoma in symptomatic patients: a prospective study | Q68229428 | ||
| Determination of CA 19-9 antigen in serum and pancreatic juice for differential diagnosis of pancreatic adenocarcinoma from chronic pancreatitis | Q68742953 | ||
| CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases | Q69824175 | ||
| Polytrauma induces increased expression of pyruvate kinase in neutrophils | Q73386764 | ||
| Value of the serum levels of the tumor marker TUM2-PK in pancreatic cancer | Q73785871 | ||
| P433 | issue | 7-8 | |
| 7/8 | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 1149-55 | |
| 1149-1155 | |||
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer | |
| Tumor M2-Pyruvate Kinase, a New Metabolic Marker for Pancreatic Cancer | |||
| P478 | volume | 49 |
| Q37277962 | A list of candidate cancer biomarkers for targeted proteomics |
| Q37790673 | Advances in pancreatic cancer detection |
| Q64102031 | Androgen receptor regulates ASS1P3/miR-34a-5p/ASS1 signaling to promote renal cell carcinoma cell growth |
| Q38089821 | Biomarkers in the diagnosis and early detection of pancreatic cancer |
| Q35375731 | Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis |
| Q37206243 | Caveolin-1: a marker for pancreatic cancer diagnosis |
| Q33865884 | Colorectal cancer screening by non-invasive metabolic biomarker fecal tumor M2-PK. |
| Q54313456 | Comparative effectiveness of pyruvate kinase M2 in bile, serum carbohydrate antigen 19-9, and biliary brushings in diagnosing malignant biliary strictures. |
| Q45404222 | Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis |
| Q58104348 | Faecal dimeric M2 pyruvate kinase in colorectal cancer and polyps correlates with tumour staging and surgical intervention |
| Q38791962 | Glucose metabolic phenotype of pancreatic cancer. |
| Q37036292 | Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer |
| Q39720192 | In vivo factors influencing tumour M2-pyruvate kinase level in human pancreatic cancer cell lines |
| Q53531433 | In-depth quantitative proteomics for pancreatic cancer biomarker discovery. |
| Q37081461 | Molecular markers of pancreatic cancer: development and clinical relevance |
| Q46866294 | Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors |
| Q38372053 | Proteome Characterization of Human Pancreatic Cyst Fluid from Intraductal Papillary Mucinous Neoplasm by LC/MS/MS. |
| Q33275224 | Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma |
| Q37824829 | Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview |
| Q38166573 | Serum tumor markers in pancreatic cancer-recent discoveries |
| Q46374039 | Tumor M2 pyruvate kinase: a tumor marker and its clinical application in gastrointestinal malignancy |
| Q93075407 | Tumor M2-PK: A novel urine marker of bladder cancer |
| Q39828227 | Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance |
Search more.